An outbreak of Mycobacterium chelonae infection after LASIK.

Authors

Freitas D, Alvarenga L, Sampaio J, et al. 

Institution

Ophthalmology Department, Federal University of São Paulo, Paulista School of Medicine, São Paulo Hospital, Rua Botucatu 822, 04023-062 São Paulo, Brazil. dfreitas@pobox.com

Source

Ophthalmology 2003 Feb; 110(2) :276-85.

Abstract

OBJECTIVE
To describe an outbreak of mycobacterial keratitis after laser in situ keratomileusis (LASIK), including the microbiologic investigation, clinical findings, treatment response, and outcome.
DESIGN
Retrospective, noncomparative, interventional case series.
PARTICIPANTS
Patients (n = 10) who underwent LASIK surgery between August 22 and September 4, 2000, and developed mycobacterial infection.
METHODS
Patients were prospectively followed in relation to microbiologic investigation, clinical findings, treatment response, and outcome.
MAIN OUTCOME MEASURES
Most patients underwent bilateral simultaneous LASIK. Postoperative infection was signaled by the appearance of corneal infiltrates in the third postoperative week. The microbiologic workup was performed on cultures obtained either by direct scraping of the cornea or by lifting the flap. Medical therapy was instituted based on drug susceptibility testing. Surgical interventions such as corneal debridement and flap removal were performed during recurrences or when there was no satisfactory clinical response.
RESULTS
Cultures revealed Mycobacterium subspecies chelonae. Patients were treated with topical clarithromycin (1%), tobramycin (1.4%), and ofloxacin (0.3%). Oral clarithromycin (500 mg twice a day) was prescribed for those patients who did not respond clinically to topical treatment. Four eyes healed on this regimen. Flap removal was necessary in seven eyes.
CONCLUSIONS
This report highlights mycobacteria as an etiologic infectious agent after LASIK. Diagnosis can be difficult and is often delayed. The treatment mainstay is prolonged antibiotic therapy. Surgical debridement and flap removal may shorten the disease course.

Mesh

Adult
Anti-Bacterial Agents
Brazil
Combined Modality Therapy
Cornea
Debridement
Disease Outbreaks
Drug Therapy, Combination
Eye Infections, Bacterial
Female
Follow-Up Studies
Humans
Keratitis
Keratomileusis, Laser In Situ
Male
Middle Aged
Mycobacterium Infections, Atypical
Mycobacterium chelonae
Prospective Studies
Reoperation
Retrospective Studies

Language

eng

Pub Type(s)

Journal Article Review

PubMed ID

12578767